PT - JOURNAL ARTICLE AU - Xinru Wan AU - Chaoyuan Cheng AU - Zhibin Zhang TI - Early transmission of COVID-19 has an optimal temperature but late transmission decreases in warm climate AID - 10.1101/2020.05.14.20102459 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.14.20102459 4099 - http://medrxiv.org/content/early/2020/05/18/2020.05.14.20102459.short 4100 - http://medrxiv.org/content/early/2020/05/18/2020.05.14.20102459.full AB - The COVID-19 novel virus, as an emerging highly pathogenic agent, has caused a pandemic. Revealing the influencing factors affecting transmission of COVID-19 is essential to take effective control measures. Several previous studies suggested that the spread of COVID-19 was likely associated with temperature and/or humidity. But, a recent extensive review indicated that conclusions on associations between climate and COVID-19 were elusive with high uncertainty due to caveats in most previous studies, such as limitations in time and space, data quality and confounding factors. In this study, by using a more extensive global dataset covering 578 time series from China, USA, Europe and the rest of the world, we show that climate show distinct impacts on early and late transmission of COVID-19 in the world after excluding the confounding factors. The early transmission ability of COVID-19 peakedaround 6.3°C without or with little human intervention, but the later transmission ability was reduced in high temperature conditions under human intervention, probably driven by increased control efficiency of COVID-19. The transmission ability was positively associated with the founding population size of early reported cases and population size of a location. Our study suggested that with the coming summer seasons, the transmission risk of COVID-19 would increase in the high-latitude or high-altitude regions but decrease in low-latitude or low-altitude regions; human intervention is essential in containing the spread of COVID-19 around the world.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialAll data related to COVID-19 patients in this this study is obtained from the official website of China’s National Health Commission, WHO and the other published databases. All data in this study do not contain private or unpublished information of patients.Funding StatementThis study was supported by the project of studying transmissions of COVID-19 and risk assessments based on big data analysis supported by the Institute of Zoology, Chinese Academy of Sciences.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be released upon the official publication of this article.